Clareo Health | Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life
Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Vaccines
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Infants of both genders who are in generally good health will be eligible for this study. For infants to be enrolled, the parents/legal representatives need to provide written informed consent and to be available for all study visits.
You may not be if
Serious, acute, or chronic illnesses are reasons for exclusion.
